A detailed history of Raymond James & Associates transactions in First Tr Ex Trad Fd Viii Cboe stock. As of the latest transaction made, Raymond James & Associates holds 16,654 shares of DOCT stock, worth $639,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,654
Previous 71,751 76.79%
Holding current value
$639,347
Previous $2.61 Million 76.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$36.12 - $37.62 $1.99 Million - $2.07 Million
-55,097 Reduced 76.79%
16,654 $626,000
Q4 2023

Jan 16, 2024

BUY
$33.71 - $36.4 $1.92 Million - $2.07 Million
56,810 Added 380.23%
71,751 $2.61 Million
Q3 2023

Oct 24, 2023

SELL
$34.49 - $35.64 $1.43 Million - $1.48 Million
-41,435 Reduced 73.5%
14,941 $517,000
Q2 2023

Jul 25, 2023

SELL
$32.76 - $34.9 $9,828 - $10,470
-300 Reduced 0.53%
56,376 $1.97 Million
Q1 2023

Apr 14, 2023

SELL
$31.12 - $32.94 $646,860 - $684,690
-20,786 Reduced 26.83%
56,676 $1.86 Million
Q4 2022

Feb 08, 2023

BUY
$30.51 - $32.08 $2.36 Million - $2.48 Million
77,462 New
77,462 $2.43 Million

Others Institutions Holding DOCT

About FIRST TR EX-TRAD FD VIII CBOE


  • Ticker DOCT
  • Sector ETFs
  • Industry ETFs
More about DOCT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.